MedTrace Logo

Clinical Validation Study of the Eximis CS (Contained Segmentation) System

NCT06572163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2025-10-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate device safety and effectiveness of the Eximis CS System.

Conditions

  • Laparoscopic Gynecological Surgical Procedures

Interventions

DEVICE

Eximis CS (Contained Segmentation) System

The Eximis CS System is an integrated system consisting of a 900 mL Capture Bag, Inflation Mechanism, two Eximis Segmenters, and the Eximis RF Generator.

Sponsors & Collaborators

  • Proxima CRO

    collaborator INDUSTRY

  • Eximis Surgical

    lead INDUSTRY

Principal Investigators

  • Scott Chudnoff, MD · Maimonides Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-20
Primary Completion
2025-09-01
Completion
2025-10-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572163 on ClinicalTrials.gov